Enhancing the anti-tumor efficacy of Bispecific T cell engagers via cell surface glycocalyx editing
Yang, Z.; Grande, G.; Hou, Y.; Wang, C.; Shi, Y.; Lerner, R. A.; Wu, P.
Show abstract
Bispecific T-cell engager (BiTE)-based cancer therapies that activate the cytotoxic T cells of a patients own immune system have gained momentum with the recent FDA approval of Blinatumomab for treating B cell malignancies. However, this approach has had limited success in targeting solid tumors. Here, we report the development of BiTE-sialidase fusion proteins that enhance tumor cell susceptibility to BiTE-mediated cytolysis by T cells via targeted desialylation at the BiTE-induced T cell-tumor cell interface. Targeted desialylation results in better immunological synapse formation, T-cell activation and effector function. As a result, BiTE-sialidase fusion proteins show remarkably increased efficacy in inducing T-cell-dependent tumor cell cytolysis in response to target antigens compared to the parent BiTE molecules alone. This enhanced function is seen both in vitro and in in vivo xenograft and syngeneic solid tumor mouse models. Our findings highlight BiTE-sialidase fusion proteins as promising candidates for the development of next-generation bispecific T-cell engaging molecules for cancer immunotherapy.
Matching journals
The top 9 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- A Mimicry-Based Strategy Between Human and Commensal Antigens for the Development of a New Family of Immune Therapies for Cancer 95%
- Molecular mechanisms underlying the modulation of T-cell proliferation and cytotoxicity by immobilized CCL21 and ICAM1 94%
- Bedside formulation of a personalized multi-neoantigen vaccine against mammary carcinoma 94%
Similar papers in this journal
Similar papers in this journal
Similar papers in this journal
- A T-cell independent universal cellular therapy strategy through antigen depletion 94%
- Focused ultrasound ablation of melanoma with boiling histotripsy yields abscopal tumor control and antigen-dependent dendritic cell activation 93%
- Single-cell transcriptome analysis of the immunosuppressive effect of differential expression of tumor PD-L1 on responding TCR-T cells 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.